| Literature DB >> 35414874 |
Alexia N Kim1, Aurapat Ngamnithiporn1,2, Michael D Bartberger3, Brian M Stoltz1.
Abstract
The development of the first asymmetric trans-selective hydrogenation of 1,3-disubstituted isoquinolines is reported. Utilizing [Ir(cod)Cl]2 and a commercially available chiral Josiphos ligand, a variety of differentially substituted isoquinolines are hydrogenated to produce enantioenriched trans-tetrahydroisoquinolines in good yield with high levels of enantioselectivity. Directing group studies demonstrate that the hydroxymethyl functionality at the C1 position is critical for hydrogenation to favor the trans-diastereomer. Preliminary mechanistic studies reveal that non-coordinating chlorinated solvents and halide additives are crucial to enable trans-selectivity. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35414874 PMCID: PMC8926345 DOI: 10.1039/d1sc06729j
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1(A) Challenges in diastereoselectivity of trans-selective arene hydrogenation. (B) Our research on iridium-catalyzed asymmetric hydrogenation of 1,3-disubstituted isoquinolines.
Optimization of the asymmetric trans-selective hydrogenationa
|
| |||||||
|---|---|---|---|---|---|---|---|
| Entry | X | Ligand | Solvent | Additive | % conv. |
| % ee of |
| 1 | OH (1a) | L1 | THF | TBAI | >95 | 1 : 15.7 | — |
| 2 | OH | L1 | CH2Cl2 | TBAI | >95 | 1 : 1.5 | 97 |
| 3 | OH | L1 | CH2Cl2 | TBABr | >95 | 2 : 1 | 93 |
| 4 | OH | L1 | CH2Cl2 | TBACl | 75 | 2.3 : 1 | 80 |
| 5 | OH | L1 | CH2Cl2 | TBAPF6 | <10 | — | — |
| 6 | OH | L2 | CH2Cl2 | TBABr | >95 | 1.8 : 1 | 94 |
| 7 | OH | L3 | CH2Cl2 | TBABr | 95 | 1.4 : 1 | 99 |
| 8 | OH | L4 | CH2Cl2 | TBABr | 45 | 1 : 2.3 | 35 |
| 9 | OH | L5 | CH2Cl2 | TBABr | 83 | 1 : 2.9 | 81 |
| 10 | OH | L1 | PhMe | TBABr | >95 | 1.2 : 1 | 91 |
| 11 | OH | L1 | EtOAc | TBABr | >95 | 1 : 1.1 | 89 |
| 12 | OH | L1 | CHCl3 | TBABr | 68 | 2.4 : 1 | 93 |
| 13 | OH | L1 | 1,2-DCE | TBABr | >95 | 2.4 : 1 | 92 |
| 14 | OMe (3a) | L1 | 1,2-DCE | TBABr | >95 | 1 : 17 | N.D. |
| 15 | OBn (3b) | L1 | 1,2-DCE | TBABr | >95 | 1 : >20 | N.D. |
| 16 | OAc (3c) | L1 | 1,2-DCE | TBABr | 57 | 1 : >20 | N.D. |
| 17 | H (3d) | L1 | 1,2-DCE | TBABr | 92 | 1 : >20 | N.D. |
| 18 | NHBoc (3e) | L1 | 1,2-DCE | TBABr | >95 | 1.4 : 1 | 25 |
| 19 | NH2 (3f) | L1 | 1,2-DCE | TBABr | 0 | — | — |
|
| |||||||
Performed on a 0.04 mmol scale.
Determined by 1H NMR analysis of the crude reaction mixture using 1,3,5-trimethoxybenzene as standard.
Determined by chiral SFC analysis of Cbz-protected trans-product.
Substrate scope of the trans-selective hydrogenation of 1,3-disubstituted isoquinolinesa
|
|
Isolated yields on a 0.2 mmol scale. SFC analysis was used to determine ee.
Determined by 1H NMR analysis of crude reaction.
Performed at 60 bar H2 and 60 °C.
Total isolated yield of inseparable diastereomers.
Scheme 1Synthetic derivatizations of product 5a.
Scheme 2Control experiments of the asymmetric trans-selective hydrogenation by using (A) TBAI instead of TBABr and (B) THF instead of 1,2-DCE.
Scheme 3Deuterium experiments of (A) D2 and CD3COOD, (B) observed β-hydride elimination pathway, (C) D2 and protic AcOH, and (D) H2 and CD3COOD.